HomeAI · summaries
Storia in 4 fonti
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals - Johnson & Johnson
Johnson & Johnson expands its biotech pipeline with Firefly Bio acquisition and a strategic partnership with Sail Biomedicines.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
- ·
biopharmadive.com
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
The deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.
